Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Andreas Seeber"'
Autor:
Andreas Seeber, Richard Greil, Joanna Szkandera, Thomas Jäger, Florian Kocher, Franz Romeder, Lukas Weiss, Thomas Brodowicz, Susanne Kostner, Thomas Kühr, Petra Pichler
Publikováno v:
Wiener klinische Wochenschrift. 133:21-25
e22550 Background: Olaratumab is a humanized monoclonal anti platelet-derived growth factor receptor α antibody that has been approved in combination with doxorubicin for the treatment of patients with metastatic soft tissue sarcoma (STS). The purpo
Autor:
Johannes Kerschbaumer, Florian Kocher, Stefan Schmidt, Dominik Wolf, Clemens Feistritzer, Andreas Seeber
Publikováno v:
Therapeutic Advances in Hematology
Therapeutic Advances in Hematology, Vol 12 (2021)
Therapeutic Advances in Hematology, Vol 12 (2021)
Patients with haemophilia A (HA) undergoing neurosurgical procedures have a high risk of haemorrhage with potential fatal outcome. Here, we present a successful perioperative haemostatic concept applying an extended half-life factor VIII (EHL FVIII),
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 17, Iss, Pp 447-453 (2019)
Computational and Structural Biotechnology Journal
Computational and Structural Biotechnology Journal
In this review we aim to summarize studies investigating the impact of a molecular profiling (MP)-guided treatment approach in heavily pretreated cancer patients. In summary, many independent single- and multicenter studies showed a significant benef
Autor:
Mira Miranova, Gayle S. Jameson, Andrew Dean, Guenther Gastl, Nicholas J. Robert, Andreas Seeber, Georges Chahine, Fadi Nasr, Heinz Zwierzina
Publikováno v:
Cancer journal (Sudbury, Mass.). 25(2)
Purpose Improvements in systemic treatment have led to a prolongation of survival and quality of life in patients with metastatic tumors in recent years. However, despite this improved standard of care, it is expected that the progression-free surviv
Autor:
Wu Zhang, Francesca Battaglin, Alberto Puccini, Jingyuan Wang, Andreas Seeber, Joshua Millstein, Madiha Naseem, Afsaneh Barzi, Shivani Soni, Sebastian Stintzing, Heinz-Josef Lenz, Volker Heinemann, Hiroyuki Arai, Ryuma Tokunaga, Yi Xiao, Martin D. Berger
Publikováno v:
Journal of Clinical Oncology. 38:190-190
190 Background: Wnt signaling deregulation is a primary driver of colorectal carcinogenesis. RNF43 is a key suppressor of Wnt activation while R-Spodin inhibits RNF43 activity. RNF43 mutations are associated with the serrated neoplasia pathway, BRAF
Autor:
Alain G. Zeimet, Dominic Fong, Laura Botta, Gilbert Spizzo, Heidi Fiegl, Agnieszka Martowicz, Mani Nassir, Ioana Braicu, Andreas Seeber, Jalid Sehouli, Normann Steiner, Gerold Untergasser, Guenther Gastl
Publikováno v:
Journal of Clinical Oncology. 32:e15173-e15173
e15173 Background: The EpCAM-specific antibody catumaxomab has been approved for intraperitoneal treatment of patients suffering from malignant ascites. New prognostic markers are necessary to sele...